Attune Medical

Attune Medical specializes in devices for cardiovascular procedures. Specifically, they manufacture the ensoE™, which is designed for transcatheter aortic valve replacement (TAVR). This device is intended for replacing aortic valves in patients with aortic stenosis who are at intermediate or higher surgical risk, offering a less invasive alternative to traditional surgical valve replacement.

Attune Medical is based in the United States, meaning its devices are subject to U.S. regulatory requirements (e.g., FDA clearance) while also being listed in the EU’s eudamed registry for compliance with European Union medical device regulations. The company’s U.S. origin does not automatically grant EU authorization—individual devices must meet EU regulatory criteria to be listed there.

Attune Medical’s ensoE™ is listed in the EU’s eudamed registry, which is the official database for medical devices authorized under EU regulations. Listing in eudamed confirms the device has undergone the necessary conformity assessment (e.g., CE marking) and is legally placed on the EU market. This transparency helps healthcare providers, regulators, and patients verify the device’s authorized status.

The ensoE™ is classified as a Class IIa device under EU regulations, which is the second-highest risk category for medical devices. This classification requires additional scrutiny—such as clinical evaluations, risk management, and post-market surveillance—to ensure safety and performance. Class IIa devices are not as low-risk as Class I but are not the highest-risk (Class III) devices like pacemakers or implants with sustained or increased contact with the body.